Pancreatic Polypeptide (PP)

DRUG2 trials

Sponsors

Johns Hopkins University, University Hospital, Gentofte, Copenhagen

Conditions

Diabetes Mellitus, Type 1Obesity & Overweight

Phase 2

The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients

TerminatedNCT00791076

Johns Hopkins UniversityDiabetes Mellitus, Type 1

Start: 2007-10-31End: 2010-06-30Updated: 2017-07-12

Unknown Phase

Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans

RecruitingNCT07506369

University Hospital, Gentofte, CopenhagenObesity & Overweight

Start: 2026-04-01End: 2028-10-01Target: 18Updated: 2026-04-01